Enavate-Sciences-Gp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
6
Total Value
132721569
Accession Number
0001415889-25-013132
Form Type
13F-HR
Manager Name
Enavate-Sciences-Gp
Data Enrichment
83% identified
5 identified1 unidentified

Holdings

6 positions • $132.7M total value
Manager:
Search and click to pin securities to the top
Immunome Inc.
Shares:4.8M
Value:$32.1M
% of Portfolio:24.2% ($32.1M/$132.7M)
Zenas BioPharma, Inc.
Shares:3.8M
Value:$29.7M
% of Portfolio:22.4% ($29.7M/$132.7M)
829401108
Shares:2.5M
Value:$25.9M
% of Portfolio:19.5% ($25.9M/$132.7M)
Camp4 Therapeutics Corp
Shares:3.8M
Value:$15.1M
% of Portfolio:11.4% ($15.1M/$132.7M)
Upstream Bio, Inc.
Shares:2.5M
Value:$15.1M
% of Portfolio:11.3% ($15.1M/$132.7M)
Compass Therapeutics, Inc.
Shares:7.8M
Value:$14.8M
% of Portfolio:11.1% ($14.8M/$132.7M)